Atopic Dermatitis Global Market is Booming Across the Globe and Witness Huge Growth By Key Players To 2033 | The Business Research Company

Overview and Scope
Atopic dermatitis is a dermatological condition that causes dryness and itching of the skin. It is a chronic condition that progresses over time and is not spread by contact.

Sizing and Forecast
The atopic dermatitis market size has grown rapidly in recent years. It will grow from $7.51 billion in 2023 to $8.7 billion in 2024 at a compound annual growth rate (CAGR) of 15.9%.  The growth in the historic period can be attributed to medical understanding and awareness, incidence and prevalence rates, patient advocacy and support, treatment options evolution, research and development.

The atopic dermatitis market size is expected to see rapid growth in the next few years. It will grow to $15.27 billion in 2028 at a compound annual growth rate (CAGR) of 15.1%.  The growth in the forecast period can be attributed to biologic therapies advancements, immunomodulators and small molecule drugs, pediatric-specific treatments, gene therapy and precision medicine, digital health integration. Major trends in the forecast period include technological advancements in topicals, pediatric ad care focus, environmental and allergen management, precision diagnosis tools..

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/atopic-dermatitis-global-market-report

Segmentation & Regional Insights
The atopic dermatitis market covered in this report is segmented –
1) By Drug Class: Corticosteroids, Emollients/Moisturizers, IL-4 and PDE4 Inhibitors, Calcineurin Inhibitors, Antibiotics, Other Drug Classes
2) By Mode of Administration: Topical, Injectable, Oral
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

North America was the largest region in the atopic dermatitis market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the atopic dermatitis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8285&type=smp

Major Driver Impacting Market Growth
The high prevalence of atopic dermatitis is expected to propel the growth of the atopic dermatitis market forward. Atopic dermatitis, also called eczema, is a skin condition that causes dryness and itchiness of the skin. The increasing prevalence of atopic dermatitis increases the need for diagnosis and treatment of the disease. For instance, according to the National Eczema Association, a US-based organization working to spread awareness related to eczema, in 2021, 31.6 million people in the US had some form of eczema, which was about 10% of the total population. Approximately 9.6 million children under the age of 18 had atopic dermatitis, and 80% of the individuals were affected by dermatitis before the age of 6 years. Therefore, the increasing prevalence of atopic dermatitis is driving the growth of the atopic dermatitis market.

Key Industry Players
Major companies operating in the atopic dermatitis market report are Sanofi SA, Meda AB, Regeneron Pharmaceuticals Inc., Novartis International AG, Pfizer Inc., AbbVie Inc., Astellas Pharma Inc., Arcutis Biotherapeutics Inc., Asana Biosciences LLC, Dermavant Sciences Inc., Eli Lilly and Company, Galderma SA, Incyte Corporation, Bayer AG, Bausch Health Companies Inc., Boehringer Ingelheim International GmbH, GlaxoSmithKline plc, F Hoffmann-La Roche AG, LEO Pharma A/S, Teva Pharmaceutical Industries Ltd., Mylan MV, Allergan plc, Encore Dermatology Inc., Menlo Therapeutics Inc., Johnson & Johnson, Merck & Co Inc., Roche Holding AG, Valeant Pharmaceuticals International Inc., Amgen Inc., AstraZeneca plc, Bristol-Myers Squibb Company, Eisai Co. Ltd., Gilead Sciences Inc., Ipsen Biopharmaceuticals Inc., Kyowa Kirin Co. Ltd., Mallinckrodt Pharmaceuticals Limited

The atopic dermatitis market report table of contents includes:
1. Executive Summary

2. Atopic Dermatitis Market Characteristics
3. Atopic Dermatitis Market Trends And Strategies
4. Atopic Dermatitis Market – Macro Economic Scenario
5. Global Atopic Dermatitis Market Size and Growth

…..

31. Global Atopic Dermatitis Market Competitive Benchmarking
32. Global Atopic Dermatitis Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Atopic Dermatitis Market
34. Atopic Dermatitis Market Future Outlook and Potential Analysis
35. Appendix

Explore the trending research reports from TBRC:

https://topprnews.com/oral-care-market-size

https://topprnews.com/panel-filters-market-growth

https://topprnews.com/non-volatile-memory-express-market

https://goodprnews.com/solar-tracker-global-market

https://goodprnews.com/warehouse-robotics-global-market

https://goodprnews.com/aeroengine-composites-global-market

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info

Healthcare Blog: https://healthcareresearchreports.com

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model